Skip to content

Waters Corporation WAT Waters Advanced Diagnostics — Operating Income Loss Margin

Similar metrics at other companies

Fortune Brands Innovations logo
FBINWater — Operating Income
$103.7M+0.5%
Mueller Water Products logo
MWAWater Management Solutions — Operating Income (Loss)
$35.3M+12.8%
Cadiz logo
CDZIWater Treatment — Operating Income
-$795K-955%
AWR
AWRWater: — Operating Income (Loss)
$38.7M+11.2%
Cadiz logo
CDZIWater And Land Resources — Operating Income
-$6.04M+20.8%
Restoration Hardware logo
RHWaterworks — Operating Income
$3.62M-31.9%

Other financials

Income statement

See full
Revenue$1.3B+91.4%
Gross profit$569.5M+8.6%
Operating income-$47.0M-131%
Net income-$72.0M-160%
EPS (diluted)-$0.87-143%

Balance sheet

See full
Cash & equivalents$462.0M+20.7%
Total debt$5.2B+263%
Total equity$15.3B+679%
Total assets$24.5B+434%

Cash flow

See full
Operating cash flow-$3.0M-101%
CapEx$39.0M+50.0%
Free cash flow-$42.0M-118%

Valuation

See full
Market cap$36.76B+78.1%
Enterprise value$41.51B+92.6%
P/E81.8×+50.6×
P/S9.8×+3.0×

Profitability

See full
Gross margin59.3%-0.1pp
Operating margin16%-12.3pp
Net margin11.9%-10.1pp
FCF margin7%-13.8pp

Returns & leverage

See full
Return on equity5.2%-35.6pp
Debt / equity0.3×-0.4×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Waters Corporation in its filing.

Tagged under the XBRL concept wat:OperatingIncomeLossMargin.

The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waters Corporation's waters advanced diagnostics — operating income loss margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waters Corporation's waters advanced diagnostics — operating income loss margin?
Waters Corporation (WAT) reported waters advanced diagnostics — operating income loss margin of 20.1% in Q1 2026.
What does waters advanced diagnostics — operating income loss margin mean?
This metric represents the operating profitability or loss generated by the Waters Advanced Diagnostics business segment, calculated as operating income divided by net sales for that specific unit. It measures the efficiency of the segment in managing its direct costs, research and development investments, and selling, general, and administrative expenses relative to the revenue it produces. This figure is critical for assessing the commercial viability and scaling potential of the company's diagnostic-focused analytical instrument and service offerings.